Qualandre strengthens 3PARL® Consortium commitment with unwavering integrity and transparent principles in Pharma Auditing
Stevenage, UK – February , 2024 – The growing community of Third-Party Audit Report Library (3PARL®) consortium members, proudly welcomes Qualandre to the group as its latest member. Qualandre’s base of operations in China, and its existing code of conduct, align seamlessly with the consortium’s mission to elevate the integrity and quality of auditing services across the life sciences industry. The 3PARL® consortium is committed to setting a new benchmark for consistent, reliable, high-quality supply chain Good Manufacturing Practice (GMP) audit services and library reports in pharmaceutical manufacturing worldwide.
Qualandre, a GMP auditing services provider based in China, specialises in evaluating manufacturing sites for pharmaceutical ingredients, medicinal products, and medical devices with a team of GMP auditors ensuring high European standards. Their commitment to transparency and trust within their code of conduct, spanning their full supply chain from auditors to quality management and computer systems, aligns seamlessly with 3PARL®’s mission to elevate integrity in supply chain audits.
In joining 3PARL®, Qualandre will reinforce the consortium’s dedication to advancing pharmaceutical auditing standards. This partnership signifies a mutual commitment to setting new standards for excellence and trustworthiness in supply chain audits, reflecting the industry’s growing recognition of 3PARL®’s significance while upholding principles of integrity and ethical standards.
Rephine’s CEO Adam Sherlock expressed enthusiasm for Qualandre’s decision to join 3PARL®. “Through our own dedicated operations in China, delivering GMP services in this strategically important market for over 18 years, we are aware of Qualandre and the quality of work which their team delivers. It is a pleasure to have them join us as members of the 3PARL® consortium and we look forward to their active participation in shaping the highest standards for performance of GMP audit services.”
Qualandre’s Philippe André shared his insights on joining 3PARL®. “We are happy to join the efforts from auditor colleagues to define and affirm their standards on reliability, transparency, and integrity of audits. Being based in China, we know the challenges of intercontinental, multi-cultural, distance from the manufacturers of products whose responsibility ultimately rests on the sponsors of our audits. It is a great pleasure to be given the opportunity to join the 3PARL® consortium and participate in shaping even higher standards of reliability.”
To find out more about 3PARL and how you can get involved please email [email protected]
About Rephine
Rephine is a firm of deeply experienced GxP consultants, auditors and practitioners. The company proactively helps pharmaceutical, biotech and medical device companies with all aspects of their manufacturing and supply chain quality assurance and associated business process optimisation.
Widely acknowledged to be the gold standard in its field, Rephine has been providing these specialist quality assurance services for more than 25 years. Rephine is a founding member of 3PARL®, a consortium that aims to set a new benchmark for consistent, reliable, high-quality supply chain Good Manufacturing Practice (GMP) audit services and library reports.
About Qualandre
Qualandre is a small auditing service based in Hangzhou, China. When we say “small,” we mean that we are focused solely on providing one type of service: conducting GMP audits for manufacturers, primarily located in China, of API and other products on behalf of their international clientele.
In our twelve years of operation, we’ve seen notable advancements in GMP compliance across the industry. However, challenges persist, which we aim to address through rigorous audit preparation. Our method prioritises thorough pre-audit technical readiness, emphasising teamwork for every audit.
More at www.qualandre.com
View our other resources and company news
Article Maintaining Data Integrity with Digital Validation
Blog Shaping the Future of Femtech to Inspire Inclusion and Innovation
Article 3PARL® Consortium grows stronger with Qualandre’s emphasis on ethical conduct and trustworthiness
Blog Innovative Solutions for Cancer Diagnosis and Prevention
Article Owlpharma joins 3PARL® to propel mission for ethical GMP supply chains in Life Sciences
GxP Consultancy Decoding the technological minefield – A tactical approach to maximising Life Sciences R&D Software implementations
Blog All change for computer software assurance in Life Sciences
Article Pharma Audit among newest members of the recently launched initiative 3PARL®
Blog